Alzheimer's disease

Although there remains no cure and only limited treatments for symptoms, there’s a bit of good news to report this year during World Alzheimer’s Month.  A handful of changes to...

23andMe recently started offering customers new Genetic Health Risk reports that have received FDA authorization. Below we’ve highlighted some important features in these reports to help you get more out...

The U.S. Food and Drug Administration granted 23andMe authorization to offer ten genetic health risk reports including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease, and a condition associated with harmful...

In what is the largest-ever genome wide association study for social science, researchers found more than 70 genetic variants associated with educational attainment – the number of years individuals spent...

If you have an opinion about genetic testing and the best way to return those results, the U.S. Food and Drug Administration (FDA) wants to hear it at a daylong...

Each year at this time 23andMe puts together a list of the most interesting genetic findings of 2013. We’re doing that again but with a twist.We want to include in...

Mounting evidence points to brain trauma as a risk factor for mental decline. Football players who’ve had multiple concussions perform worse on tests of brain function and are more likely...

Editor’s note: This post has been edited from its original to reflect changes in our product. 23andMe reports on a genetic variant associated with risk for Late Onset Alzheimer’s Disease....

In honor of World Alzheimer’s Day, we’re linking to a few posts and stories about the disease. Alzheimer’s disease is the most common form of dementia and affects more than...

23andMe founder and CEO Anne Wojcicki talks about new research into genetic factors correlated with risk for degenerative brain disease in response to traumatic brain injury.